Generation of multipotent lung and airway progenitors from mouse ESCs and patient-specific cystic fibrosis iPSCs

  • Hongmei Mou
  • , Rui Zhao
  • , Richard Sherwood
  • , Tim Ahfeldt
  • , Allen Lapey
  • , John Wain
  • , Leonard Sicilian
  • , Konstantin Izvolsky
  • , Kiran Musunuru
  • , Chad Cowan
  • , Jayaraj Rajagopal

Research output: Contribution to journalArticlepeer-review

290 Scopus citations

Abstract

Deriving lung progenitors from patient-specific pluripotent cells is a key step in producing differentiated lung epithelium for disease modeling and transplantation. By mimicking the signaling events that occur during mouse lung development, we generated murine lung progenitors in a series of discrete steps. Definitive endoderm derived from mouse embryonic stem cells (ESCs) was converted into foregut endoderm, then into replicating Nkx2.1+ lung endoderm, and finally into multipotent embryonic lung progenitor and airway progenitor cells. We demonstrated that precisely-timed BMP, FGF, and WNT signaling are required for NKX2.1 induction. Mouse ESC-derived Nkx2.1+ progenitor cells formed respiratory epithelium (tracheospheres) when transplanted subcutaneously into mice. We then adapted this strategy to produce disease-specific lung progenitor cells from human Cystic Fibrosis induced pluripotent stem cells (iPSCs), creating a platform for dissecting human lung disease. These disease-specific human lung progenitors formed respiratory epithelium when subcutaneously engrafted into immunodeficient mice.

Original languageEnglish
Pages (from-to)385-397
Number of pages13
JournalCell Stem Cell
Volume10
Issue number4
DOIs
StatePublished - 6 Apr 2012
Externally publishedYes

Fingerprint

Dive into the research topics of 'Generation of multipotent lung and airway progenitors from mouse ESCs and patient-specific cystic fibrosis iPSCs'. Together they form a unique fingerprint.

Cite this